155 related articles for article (PubMed ID: 10963680)
1. Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator.
Geck P; Maffini MV; Szelei J; Sonnenschein C; Soto AM
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10185-90. PubMed ID: 10963680
[TBL] [Abstract][Full Text] [Related]
2. Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.
Geck P; Szelei J; Jimenez J; Sonnenschein C; Soto AM
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):41-50. PubMed ID: 10215036
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of androgen action on cell proliferation: AS3 protein as a mediator of proliferative arrest in the rat prostate.
Maffini MV; Geck P; Powell CE; Sonnenschein C; Soto AM
Endocrinology; 2002 Jul; 143(7):2708-14. PubMed ID: 12072405
[TBL] [Abstract][Full Text] [Related]
4. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
5. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
6. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element.
Riegman PH; Vlietstra RJ; van der Korput JA; Brinkmann AO; Trapman J
Mol Endocrinol; 1991 Dec; 5(12):1921-30. PubMed ID: 1724287
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
9. Correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma.
Zhang Y; Huang X; Qi J; Yan C; Xu X; Han Y; Wang M
J Genet Genomics; 2008 May; 35(5):267-71. PubMed ID: 18499069
[TBL] [Abstract][Full Text] [Related]
10. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
11. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
[TBL] [Abstract][Full Text] [Related]
12. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
[TBL] [Abstract][Full Text] [Related]
13. Regulation of S100P expression by androgen.
Averboukh L; Liang P; Kantoff PW; Pardee AB
Prostate; 1996 Dec; 29(6):350-5. PubMed ID: 8977631
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
15. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells.
Geck P; Szelei J; Jimenez J; Lin TM; Sonnenschein C; Soto AM
J Steroid Biochem Mol Biol; 1997; 63(4-6):211-8. PubMed ID: 9459187
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
17. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
20. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
